References
Hughes, B. Evolving R&D for emerging markets. Nature Rev. Drug Discov. 9, 417–420 (2010).
National Science Foundation. Division of Science Resources Statistics. Asia's Rising Science and Technology Strength: Comparative Indicators for Asia, the European Union, and the United States. National Science Foundation website [online], (2007).
Organisation for Economic Co-operation and Development (OECD). Education at a Glance 2009: OECD Indicators 1–472 (OECD Publishing, Paris, 2009).
National Science Foundation. Doctorate Recipients from U. S. Universities: Summary Report 2007–08. National Science Foundation website [online], (2009).
National Science Foundation. National Science Board: Science and Engineering Indicators 2010. National Science Foundation website [online], (2010).
IMS Health. IMS Market Prognosis. (IMS Health, March 2009).
US Department of Commerce, United States Patent and Trademark Office. Manual of Patent Examining Procedure (US Patent and Trademark Office, Virginia, 2010).
Light, D. W. Global drug discovery: Europe is ahead. Health Aff. 28, 969–977 (2009).
Author information
Authors and Affiliations
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Friedman, Y. Location of pharmaceutical innovation: 2000–2009. Nat Rev Drug Discov 9, 835–836 (2010). https://doi.org/10.1038/nrd3298
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3298
- Springer Nature Limited
This article is cited by
-
Obstacles and opportunities in Chinese pharmaceutical innovation
Globalization and Health (2017)
-
The performance of China’s biomedical innovation: a scientometric analysis
Science China Life Sciences (2016)
-
Pharmaceutical regulation in Europe and its impact on corporate R&D
Health Economics Review (2014)
-
The nature of Asian biopharmaceutical innovation
Nature Biotechnology (2014)
-
Defining “Innovativeness” in Drug Development: A Systematic Review
Clinical Pharmacology & Therapeutics (2013)